Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity

1 Mar 1990

Abstract excerpt

A variety of chemically different compounds inhibit the replication of several serotypes of rhinoviruses (common-cold viruses). We noticed that one of these antiviral compounds, WIN 51711, had an antiviral spectrum clearly distinctive from a consensus spectrum or other capsid-binding compounds, although all of them were shown to share the same binding site. A systematic evaluation of all known rhinovirus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Disease Management and Epidemiology
Share to Respiratory viral infections research
Share to Viral Infections and Immunology Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 2154596
DOI: 10.1128/jvi.64.3.1117-1123.1990

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicityPMID 2154596Read ↗

VP1 Sequencing of All Human Rhinovirus Serotypes:Insights into Genus Phylogeny and Susceptibility to AntiviralCapsid-BindingCompoundsSemantic proximity Read ↗

The human rhinovirus: human‐pathological impact, mechanisms of antirhinoviral agents, and strategies for their discoverySemantic proximity Read ↗

Human rhinoviruses: coming in from the coldSemantic proximity Read ↗

Antiviral capsid-binding compounds can inhibit the adsorption of minor receptor rhinoviruses.Semantic proximity Read ↗

Selective human enterovirus and rhinovirus inhibitors: An overview of capsid‐binding and protease‐inhibiting moleculesSemantic proximity Read ↗

Alignment of capsid protein VP1 sequences of all human rhinovirus prototype strains: conserved motifs and functional domainsSemantic proximity Read ↗

Newly identified human rhinoviruses: molecular methods heat up the cold virusesSemantic proximity Read ↗

Molecular mechanism of rhinovirus escape from the Pyrazolo[3,4-d]pyrimidine capsid-binding inhibitor OBR-5-340 via mutations distant from the binding pocket: Derivatives that brake resistance.Semantic proximity Read ↗

Human Rhinovirus Diversity and Evolution: How Strange the Change from Major to MinorSemantic proximity Read ↗

Comparative analysis of the molecular mechanism of resistance to vapendavir across a panel of picornavirus speciesSemantic proximity Read ↗

Viral entry pathways: the example of common cold virusesSemantic proximity Read ↗

Molecular relationships between 21 human rhinovirus serotypesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.